New Drug Application Filing for Ibrutinib Accepted in Two B-cell Malignancies by the U.S. FDA

New Drug Application Filing for Ibrutinib Accepted in Two B-cell Malignancies by the U.S. FDA

This is NOT an approval, it is the beginning of the approval process but only for two uses or indications... previously treated mantle cell lymphoma (MCL) and previously treated chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).

online.wsj.com/article/PR-C...

Another step forward in the approval process...

Last edited by
oldestnewest

You may also like...